Synaptic Medical develops diagnostic and therapeutic devices and consumables for cardiac electrophysiology, targeting atrial fibrillation and other rapid arrhythmias. Founded in 2005 in Minnesota with a Beijing subsidiary established in 2007, the company pursues an innovation-driven, internationalized strategy to replace imported products. It currently offers more than ten product lines, holds registrations in the U.S., EU and Japan, and sells into nearly 800 hospitals across China. In recent years Synaptic has grown at an approximate 40–50% compound annual rate while capturing share from incumbent global vendors. The firm opened an innovation R&D center in California in 2020 to collaborate with its China team and accelerate product development. Synaptic plans to expand its product lines, deepen import substitution and push further internationalization to become a platform leader in the electrophysiology market.

Total raised

$60M

Funding rounds

1

Latest round

Series G

Latest activity

Mar 2021